Envista Holdings Co. (NYSE:NVST) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Envista Holdings Co. (NYSE:NVST - Get Free Report) have been given an average recommendation of "Hold" by the fifteen research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $20.23.

A number of equities analysts recently issued reports on NVST shares. Robert W. Baird raised shares of Envista from a "neutral" rating to an "outperform" rating and boosted their target price for the stock from $21.00 to $23.00 in a research report on Tuesday. JPMorgan Chase & Co. dropped their price objective on shares of Envista from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Thursday, March 6th. Bank of America decreased their target price on Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. UBS Group cut their price target on Envista from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Monday, May 5th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Envista in a report on Thursday, March 6th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Treasurer of the State of North Carolina grew its holdings in shares of Envista by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock worth $1,458,000 after purchasing an additional 480 shares during the last quarter. Amalgamated Bank lifted its position in Envista by 0.7% during the 4th quarter. Amalgamated Bank now owns 80,380 shares of the company's stock worth $1,551,000 after buying an additional 523 shares in the last quarter. M&T Bank Corp grew its holdings in Envista by 4.2% during the 4th quarter. M&T Bank Corp now owns 16,621 shares of the company's stock worth $320,000 after acquiring an additional 676 shares during the last quarter. Assetmark Inc. grew its holdings in Envista by 2.5% during the 4th quarter. Assetmark Inc. now owns 39,624 shares of the company's stock worth $764,000 after acquiring an additional 983 shares during the last quarter. Finally, Xponance Inc. increased its position in Envista by 5.8% in the 4th quarter. Xponance Inc. now owns 19,726 shares of the company's stock valued at $381,000 after acquiring an additional 1,077 shares in the last quarter.

Envista Stock Performance

NVST stock traded down $0.17 during mid-day trading on Thursday, reaching $18.29. 2,560,792 shares of the stock traded hands, compared to its average volume of 2,572,221. The firm has a market capitalization of $3.10 billion, a PE ratio of -2.82, a P/E/G ratio of 1.27 and a beta of 0.97. The business has a 50-day moving average of $16.64 and a two-hundred day moving average of $18.76. Envista has a 52 week low of $14.22 and a 52 week high of $23.00. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44.

Envista (NYSE:NVST - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. The firm had revenue of $616.90 million for the quarter, compared to analyst estimates of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The company's revenue was down 1.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.26 EPS. As a group, equities analysts predict that Envista will post 1 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.